Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KNSA |
---|---|---|
09:32 ET | 1833 | 18.48 |
09:39 ET | 510 | 18.6541 |
09:48 ET | 105 | 18.565 |
09:50 ET | 300 | 18.515 |
09:52 ET | 6882 | 18.49 |
09:56 ET | 2105 | 18.56 |
09:57 ET | 150 | 18.5301 |
09:59 ET | 100 | 18.59 |
10:01 ET | 400 | 18.5363 |
10:08 ET | 406 | 18.53 |
10:10 ET | 100 | 18.53 |
10:12 ET | 2695 | 18.49 |
10:14 ET | 837 | 18.48 |
10:15 ET | 100 | 18.49 |
10:17 ET | 885 | 18.55 |
10:24 ET | 100 | 18.56 |
10:26 ET | 100 | 18.58 |
10:28 ET | 200 | 18.6 |
10:32 ET | 100 | 18.58 |
10:33 ET | 176 | 18.581 |
10:35 ET | 400 | 18.56 |
10:39 ET | 200 | 18.51 |
10:42 ET | 202 | 18.5 |
10:44 ET | 210 | 18.5 |
10:46 ET | 200 | 18.54 |
10:50 ET | 1000 | 18.545 |
10:53 ET | 100 | 18.555 |
10:57 ET | 415 | 18.5799 |
11:08 ET | 615 | 18.61 |
11:15 ET | 100 | 18.615 |
11:24 ET | 200 | 18.58 |
11:27 ET | 101 | 18.64 |
11:31 ET | 100 | 18.635 |
11:36 ET | 100 | 18.65 |
11:40 ET | 1340 | 18.62 |
11:42 ET | 100 | 18.64 |
11:44 ET | 1317 | 18.63 |
11:54 ET | 100 | 18.61 |
12:03 ET | 107 | 18.58 |
12:12 ET | 470 | 18.5801 |
12:16 ET | 1000 | 18.62 |
12:23 ET | 100 | 18.62 |
12:27 ET | 100 | 18.61 |
12:34 ET | 1242 | 18.58 |
12:38 ET | 100 | 18.57 |
12:39 ET | 951 | 18.65 |
12:45 ET | 100 | 18.645 |
12:50 ET | 100 | 18.645 |
12:56 ET | 335 | 18.645 |
01:08 ET | 8675 | 18.68 |
01:14 ET | 200 | 18.71 |
01:15 ET | 121 | 18.73 |
01:30 ET | 100 | 18.715 |
01:37 ET | 100 | 18.715 |
01:42 ET | 1296 | 18.69 |
01:44 ET | 1313 | 18.72 |
01:57 ET | 960 | 18.69 |
02:00 ET | 990 | 18.7 |
02:08 ET | 100 | 18.7 |
02:09 ET | 300 | 18.7 |
02:18 ET | 100 | 18.7 |
02:24 ET | 701 | 18.72 |
02:26 ET | 600 | 18.73 |
02:27 ET | 100 | 18.71 |
02:36 ET | 100 | 18.7 |
02:38 ET | 900 | 18.7 |
02:42 ET | 990 | 18.7 |
02:44 ET | 524 | 18.72 |
02:45 ET | 300 | 18.71 |
02:49 ET | 100 | 18.71 |
02:51 ET | 300 | 18.75 |
02:54 ET | 100 | 18.74 |
02:58 ET | 500 | 18.77 |
03:02 ET | 100 | 18.76 |
03:05 ET | 100 | 18.75 |
03:07 ET | 100 | 18.76 |
03:12 ET | 1369 | 18.78 |
03:16 ET | 812 | 18.82 |
03:18 ET | 637 | 18.81 |
03:20 ET | 100 | 18.8 |
03:34 ET | 1028 | 18.85 |
03:38 ET | 700 | 18.85 |
03:39 ET | 1200 | 18.79 |
03:41 ET | 100 | 18.82 |
03:43 ET | 352 | 18.82 |
03:45 ET | 500 | 18.79 |
03:48 ET | 600 | 18.79 |
03:50 ET | 101 | 18.8 |
03:52 ET | 400 | 18.79 |
03:54 ET | 2563 | 18.8 |
03:56 ET | 1600 | 18.775 |
03:57 ET | 4824 | 18.76 |
03:59 ET | 7692 | 18.77 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.3B | 220.3x | --- |
Dynavax Technologies Corp | 1.5B | 231.2x | --- |
Ginkgo Bioworks Holdings Inc | 994.4M | -1.0x | --- |
BioCryst Pharmaceuticals Inc | 1.3B | -5.8x | --- |
MannKind Corp | 1.3B | 204.9x | --- |
Zai Lab Ltd | 1.9B | -5.3x | --- |
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $301.8M |
Shares Outstanding | 70.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $0.09 |
Book Value | $6.23 |
P/E Ratio | 220.3x |
Price/Sales (TTM) | 4.4 |
Price/Cash Flow (TTM) | 122.6x |
Operating Margin | -10.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.